Health Trials

Hypercalciuria

2

Review clinical trials related to Hypercalciuria. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria

This study evaluates the efficacy of rifampin in the treatment of hypercalcemia and/or hypercalciuria in participants with at least one inactivating mutation of the CYP24A1 gene. Eligible subjects will receive rifampin for a total of 16 weeks during this study.

Participants needed: 60
Trial details
Phase: Phase 2Age: 6-65Biological sex: AllType: InterventionalSponsor: Children's Hospital of PhiladelphiaUpdated: Jun 22, 2026Locations: 1
Eligibility criteria

Males or females age 6 months to 65 years. [+4]

Parents/guardians or subjects who, in the opinion of the Investigator, may be no... [+4]

Read more
Status: Recruiting

The Impact of Phosphate Metabolism on Healthy Aging

Determine the association between duration and dose of chronic conventional therapy with Pi and renal (nephrocalcinosis/nephrolithiasis), vascular (endothelial function), and cardiovascular function (echo- cardiography) in patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH) and patients with X-linked hypophosphatemia (XLH).

Participants needed: 30
Trial details
Phase: Early Phase 1Age: 13+Biological sex: AllType: InterventionalSponsor: Yale UniversityUpdated: May 27, 2026Locations: 1
Eligibility criteria

Children above the age of 13 years [+4]

Subjects will be excluded, if they are children younger than age 13 years [+4]

Read more